High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis

Genes Chromosomes and Cancer

Volumn 50, Issue 6, 2011, Pages 397-408

  Paulson, Vera ^a,b   Chandler, Garvin ^a,b   Rakheja, Dinesh ^a,c   Galindo, Rene L ^a,b,c   Wilson, Kathleen ^a   Amatruda, James F ^a,b   Cameron, Scott ^a,b,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; FIBROBLAST GROWTH FACTOR RECEPTOR 4; PROTEIN P53; RAS PROTEIN; RETINOBLASTOMA PROTEIN; SONIC HEDGEHOG PROTEIN;

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; EMBRYONAL RHABDOMYOSARCOMA; GENE ACTIVATION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION;

CHILD; CHILD, PRESCHOOL; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; MALE; NEOPLASM STAGING; NEUROFIBROMATOSIS 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RHABDOMYOSARCOMA; SEQUENCE DELETION;

ERINACEIDAE;

EID: 79954419662     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20864     Document Type: Article

References (46)

1. Arlt MF, Mulle JG, Schaibley VM, Ragland RL, Durkin SG, Warren ST, Glover TW. 2009. Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am J Hum Genet 84: 339-350.
2. Balgobind BV, Van Vlierberghe P, van den Ouweland AMW, Beverloo HB, Terlouw-Kromosoeto JNR, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJL, Pieters R, Zwaan CM, Van den Heuvel-Eibrink MM, Meijerink JPP. 2008. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood 111: 4322-4328.
3. Beachy PA, Karhadkar SS, Berman DM. 2004. Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324-331.
4. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, Perner S, Prensner J, Debiasi RM, Demichelis F, Hatton C, Rubin MA, Garraway LA, Nelson SF, Liau L, Mischel PS, Cloughesy TF, Meyerson M, Golub TA, Lander ES, Mellinghoff IK, Sellers WR. 2007. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104: 20007-20012.
5. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Henry KTM, Pinchback RM, Ligon AH, Cho Y, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao M, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M. 2010. The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
6. Bridge J, Liu J, Weibolt V, Baker K, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R. 2000. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 27: 337-344.
7. Bridge J, Liu J, Qualman S, Suijkerbuijk R, Wenger G, Zhang J, Wan X, Baker K, Sorensen P, Barr F. 2002. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33: 310-321.
8. Calzada-Wack J, Schnitzbauer U, Walch A, Wurster KH, Kappler R, Nathrath M, Hahn 2002. Analysis of the PTCH coding region in human rhabdomyosarcoma. Hum Mutat 20: 233-234.
9. Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO, Yang F, Pineda M, Helman LJ, Meltzer PS. 2010. Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res 70: 6497-6508.
10. Chen Y, Takita J, Mizuguchi M, Tanaka K, Ida K, Koh K, Igarashi T, Hanada R, Tanaka Y, Park M-J, Hayashi Y. 2007. Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression. Genes Chromosomes Cancer 46: 348-358.
11. Davicioni E, Anderson M, Finckenstein F, Lynch J, Qualman S, Shimada H, Schofield D, Buckley J, Meyer, Sorensen P, Triche T. 2009. Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis. A report from the Children's Oncology Group. Am J Pathol 174: 550-564.
12. De Giovanni C, Landuzzi L, Nicoletti G, Lollini P, Nanni P. 2009. Molecular and cellular biology of rhabdomyosarcoma. Future Oncol 5: 1449-1475.
13. Eberhart CG. 2003. Medulloblastoma in mice lacking p53 and PARP: all roads lead to Gli. Am J Pathol 162: 7-10.
14. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. 2004. A census of human cancer genes. Nat Rev Cancer 4: 177-183.
15. Gailani MR, Stahle-Backdahl M, Leffell DJ, Glyn M, Zaphiropoulos PG, Unden AB, Dean M, Brash DE, Bale AE, Toftgard R. 1996. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14: 78-81.
16. Gordon T, McManus A, Anderson J, Min T, Swansbury J, Pritchard-Jones K, Shipley J, Group UkCCS, Group UKCC. 2001. Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study. Med Pediatr Oncol 36: 259-267.
17. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE. 1996. Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841-851.
18. Hahn H, Wojnowski L, Zimmer A, Hall J, Miller G, Zimmer A. 1998. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 4: 619-622.
19. Iolascon A, Faienza M, Coppola B, Rosolen A, Basso G, Della Ragione F, Schettini F. 1996. Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma. Genes Chromosomes Cancer 15: 217-222.
20. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH, Jr., Scott MP. 1996. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668-1671.
21. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y. 2008. KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: D480-D484.
22. Khan J, Wei JS, Ringnér M, Saal LH, Ladanyi, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS. 2001. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7: 673-679.
23. Kim WY, Sharpless NE. 2006. The regulation of INK4/ARF in cancer and aging. Cell 127: 265-275.
24. Lam CW, Xie J, To KF, Ng HK, Lee KC, Yuen NW, Lim PL, Chan LY, Tong SF, McCormick F. 1999. A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene 18: 833-836.
25. Langenau D, Keefe M, Storer N, Guyon J, Kutok J, Le X, Goessling W, Neuberg D, Kunkel L, Zon L. 2007. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 21: 1382-1395.
26. Le LQ, Parada LF. 2007. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 26: 4609-4616.
27. Lee Y, Kawagoe R, Sasai K, Li Y, Russell HR, Curran T, McKinnon PJ. 2007. Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 26: 6442-6447.
28. Mao J, Ligon K, Rakhlin E, Thayer S, Bronson R, Rowitch D, Mcmahon A. 2006. A novel somatic mouse model to survey tumorigenic potential applied to the hedgehog pathway. Cancer Res 66: 10171-10178.
29. Martinelli S, McDowell HP, Vigne SD, Kokai G, Uccini S, Tartaglia M, Dominici C. 2009. RAS signaling dysregulation in human embryonal Rhabdomyosarcoma. Genes Chromosomes Cancer 48: 975-982.
30. Mullor JL, Dahmane N, Sun T, i Altaba AR. 2001. Wnt signals are targets and mediators of Gli function. Curr Biol 11: 769-773.
31. Network CGAR. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
32. Pandita A, Zielenska M, Thorner P, Bayani J, Godbout R, Greenberg M, Squire J. 1999. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. NEO 1: 262-275.
33. Persons DL, Bui MM, Lowery MC, Mark HF, Yung JF, Birkmeier JM, Wong EY, Yang SJ, Masood S. 2000. Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study. Ann Clin Lab Sci 30: 41-48.
34. Qualman S, Coffin C, Newton W, Hojo H, Triche T, Parham D, Crist W. 1998. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1: 550-561.
35. Sambrook J, Russell DW. 2006. Preparation of genomic DNA from mouse tails and other small samples. Cold Spring Harb Protoc p pdb.prot4038.
36. Sangha N, Wu R, Kuick R, Powers S, Mu D, Fiander D, Yuen K, Katabuchi H, Tashiro H, Fearon ER, Cho KR. 2008. Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. NEO 10: 1362-1372, following 1372.
37. Schaaf G, Hamdi M, Zwijnenburg D, Lakeman A, Geerts D, Versteeg R, Kool M. 2010. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene. Cancer Res 70: 762-771.
38. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
39. Taipale J, Beachy PA. 2001. The Hedgehog and Wnt signalling pathways in cancer. Nature 411: 349-354.
40. Taylor JG, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman, Hewitt SM, Merlino, Chanock SJ, Khan J. 2009. Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest 119: 3395-3407.
41. Tostar U, Malm C, Meis-Kindblom J, Kindblom L, Toftgård R, Undén A. 2005. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol 208: 17-25.
42. Williamson D, Missiaglia E, De Reynies A, Pierron G, Thuille B, Palenzuela G, Thway K, Orbach D, Lae M, Freneaux P, Pritchard-Jones K, Oberlin O, Shipley J, Delattre O. 2010. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 28: 1-24.
43. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. 1997. Mutations in the human homologue of the drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57: 2581-2585.
44. Xia SJ, Pressey JG, Barr FG. 2002. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 1: 97-104.
45. Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, Menon AG, Warren RS, Chen L-C, Scott MP, Epstein EH, Jr. 1997. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res 57: 2369-2372.
46. Zibat A, Missiaglia E, Rosenberger A, Pritchard-Jones K, Shipley J, Hahn H, Fulda S. 2010. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Oncogene 29: 6323-6330.